Liverpool has been praised for its role in leading Europe in the field of next-generation life science manufacturing.
The city's thriving science scene has been highlighted by a number of global experts, who say the sector will double in high-quality jobs over the next five years, and that Liverpool, including Speke, are "key areas" for the growth.
It came as the 海角视频 Bioindustry Association held its major national industry conference at St George's Hall last week.
READ MORE: {}
Steve Bates, CEO of the 海角视频 Bioindustry Association, said: “Liverpool is known around the globe for its world class football, but it’s less well known in the city that it’s also a world class location for innovative life science manufacturing.
"This is an industry set to double in jobs in the 海角视频 in the next five years and will need skilled workers.
"Global experts are meeting to discuss how to make the medicines of the future - and the region is well set to benefit from the growth of this 海角视频 innovation ecosystem success story.”
Liverpool City Region Business News
According to Mr Bates, Liverpool is a global hub for Research and Development in infectious disease, biomanufacturing, precision medicine and digital health and IT.
The region's healthcare sector employs over 125,000 people, and there are more specialist hospitals and health centres than any other city outside of London.
Most Read
He also pointed to the world's first factory to use genetically modified bacteria in the production of medicine - Eli Lilly, which is based in Speke.
Follow North West Business Editor Tom Houghton
Tom Houghton is the North West Business Editor for BusinessLive and Reach plc titles.
You can follow Tom on Twitter , or contact him on .
Email him on tom.houghton@reachplc.com.
Keep up to date with the latest breaking news in the North West here.
Sign up to our fantastic daily email updates for the region .
Follow and on Twitter
A presentation at the conference from Dr Derek Ellison of global pharmaceutical company Allergan Biologics said his firm had recently achieved licensure for its state of the art development and clinical manufacturing facility in Speke, which has recently been redeveloped.
The average booked capacity for 2019 is already at 72% with gene therapy-dedicated capacity "completely booked".
A total of 1,139 full-time staff are employed across 146 cleanrooms, which Mr Bates said was significantly higher than the 555 full-time staff captured in the 2018 survey.